Saravanan Pushpanathan
About Saravanan Pushpanathan
Data last updated:
Saravanan Pushpanathan is a Managing Director at Sarsun Private Limited (since 2021). The companies operate in Healthcare. Sarsun Private Limited reported revenue of ₹1,560 (FY 2025). Earlier, Saravanan Pushpanathan was a Director at Analyze Biotech Private Limited (2013–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sarsun Private Limited U85100TN2021PTC148405 | Managing Director | 06 Dec 2021 | 2021 | ₹1,560 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Analyze Biotech Private Limited U32509TN2011PTC083398 | Director | 12 Jun 2013 | 2011 | ₹16.5 Lakh (FY 2017) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Saravanan Pushpanathan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anujadevi | 09425936 | Sarsun Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saravanan Pushpanathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saravanan Pushpanathan
Saravanan Pushpanathan currently holds 1 directorship: Sarsun Private Limited (Managing Director, since 06 Dec 2021, revenue ₹1,560 (FY 2025)).
Saravanan Pushpanathan was first appointed on 12 Jun 2013 as Director at Analyze Biotech Private Limited. The most recent appointment on record is 06 Dec 2021 at Sarsun Private Limited.
Saravanan Pushpanathan held 1 earlier board appointment: Analyze Biotech Private Limited (Director, 12 Jun 2013 to 18 Nov 2021).
The current boards of Saravanan Pushpanathan's companies include Anujadevi (Sarsun Private Limited).